scholarly journals Replacement of an extensive chest wall defect in combination with the elimination of postoperative ventral hernia after combined treatment of breast cancer complicated by osteomyelitis of the sternum and ribs

2021 ◽  
Vol 180 (2) ◽  
pp. 78-82
Author(s):  
E. B. Topolnitskiy ◽  
R. A. Mikhed ◽  
E. S. Marchenko ◽  
T. L. Chekalkin ◽  
S. V. Gunter
Keyword(s):  
Breast Cancer ◽  
Surgical Treatment ◽  
Ventral Hernia ◽  
Chest Wall ◽  
Combined Treatment ◽  
Wall Defect ◽  
Chest Wall Defect ◽  
Excellent Functional Result ◽  
Implant Displacement

Plastic replacement of osteochondral defect of the chest wall after surgical treatment of osteomyelitis of the sternum and ribs is a complex and topical issue in surgery. Often, an extensive post-resected defect of the sternum and ribs is combined with instability of the frame of the chest wall and thoracoabdominal hernia, which leads to physiological and socio-psychological maladaptation of the patient. The case of successful replacement of an extensive chest wall defect in combination with a ventral hernia in a patient after combined treatment of breast cancer complicated by osteomyelitis of the sternum and ribs is presented. TiNi- reinforcing rib prostheses and TiNi-mesh were used to create the frame of the chest wall and hernioplasty. 5-year follow-up did not reveal a recurrence of osteomyelitis and ventral hernia, implant displacement and instability of the frame of the chest wall. The method of reconstruction of an extensive thoracoabdominal defect using bioadaptive implants from TiNi is safe and effective in patients at the final stage of surgical treatment of osteomyelitis of the chest wall including in combination with ventral hernia. Thanks to the developed technology, an excellent functional result was achieved.

scholarly journals Pedicled Latissimus Dorsi Kiss Flap for the Reconstruction of Large Chest Wall Defect After Mastectomy

2021 ◽  
Author(s):  
Shengchao Huang ◽  
Pu Qiu ◽  
Jianwen Li ◽  
Weizhang Chen ◽  
Zhongzeng Liang ◽  
...  
Keyword(s):  
Chest Wall ◽  
Latissimus Dorsi ◽  
Locally Advanced Breast Cancer ◽  
Locally Advanced ◽  
Breast Tumors ◽  
Extensive Resection ◽  
Wall Defect ◽  
Chest Wall Defect ◽  
Donor Area

Abstract To discover the utility of pedicled latissimus dorsi kiss flap for the reconstruction of chest wall defect after mastectomy. This study was a systemic analysis of 12 female patients with breast tumors who were treated at Affiliated Hospital of Guangdong Medical University from January 2018 to December 2019. Among them, three patients had malignant lobular breast tumors, and nine patients had locally advanced breast cancer. After extensive resection of the primary tumor, the chest wall skin, and soft tissue, a large defect was left in the chest wall of each patient. Based on the design and structure of the kiss flap, two semicircular flaps of equal diameter were designed in the latissimus dorsi region, and their blood supply was retained from the same vascular trunk. Two flaps were transferred to the chest wall through a subcutaneous tunnel, and the incision in the donor area was sutured directly. Finally, two equal semicircle flaps were adjusted to fit the defect and then fixed on the chest wall. Referred to the design of the kiss flap, the area of the latissimus dorsi was increased to cover a larger chest wall defect. We have used this flap to reconstruct chest wall defects on twelve patients. Their age ranged from 24 to 62. The largest defect was 20 × 12 cm, and the smallest defect was 15 × 10 cm in diameter. Postoperative follow-up time was 5–9 months (mean time: 6.2 months): Follow-up observations demonstrated that all the flaps were healed well without edema or extravasation and donor area of all cases was closed well. In addition, no local recurrence or distant metastasis was observed in all patients.

scholarly journals Delayed syndrome of thoracic insufficiency: a consequence of non-rigid reconstruction of a large chest wall defect

2011 ◽  
Vol 41 (4) ◽  
pp. 953-954 ◽  
Author(s):  
J.-P. Berthet ◽  
T. D'Annoville ◽  
L. Canaud ◽  
C.-H. Marty-Ane
Keyword(s):  
Chest Wall ◽  
Wall Defect ◽  
Chest Wall Defect

Surgical Outcomes in Reconstruction of Chest Wall Defect After Radical Resection for Malignant Tumours

2019 ◽  
Vol 28 ◽  
pp. S120
Author(s):  
Seok Kim ◽  
Sang Yun Song ◽  
Kwang Seog Kim ◽  
Ju Sik Yun ◽  
Kook Joo Na
Keyword(s):  
Chest Wall ◽  
Surgical Outcomes ◽  
Radical Resection ◽  
Malignant Tumours ◽  
Wall Defect ◽  
Chest Wall Defect

scholarly journals Three-Dimensional Printing PEEK Implant: A Novel Choice for the Reconstruction of Chest Wall Defect

2019 ◽  
Vol 107 (3) ◽  
pp. 921-928 ◽  
Author(s):  
Lei Wang ◽  
Lijun Huang ◽  
Xiaofei Li ◽  
Daixing Zhong ◽  
Dichen Li ◽  
...  
Keyword(s):  
Chest Wall ◽  
Three Dimensional ◽  
Wall Defect ◽  
Three Dimensional Printing ◽  
Chest Wall Defect ◽  
Dimensional Printing

Electrochemotherapy for cutaneous metastases in breast cancer: Experience from a designated treatment centre.

2015 ◽  
Vol 33 (28_suppl) ◽  
pp. 48-48
Author(s):  
Shramana Mitul Banerjee ◽  
Jackie Newby ◽  
Shahab Khan ◽  
Virginia Homfray ◽  
Diane Whittaker ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Disease Progression ◽  
Cancer Patients ◽  
Chest Wall ◽  
Chemotherapeutic Agents ◽  
Post Treatment ◽  
Breast Cancer Patients ◽  
Cutaneous Metastases ◽  
Treatment Centre

48 Background: Electrochemotherapy (ECT) combines the administration of poorly permeable chemotherapeutic agents with electroporation. It has been shown to be effective when compared with other treatments. This study assessed how breast cancer patients were benefited and identified potential problems at a designated treatment centre. Methods: This was a single centre prospective study of patients with cutaneous metastases from breast cancer. Patients who fulfilled NICE UK (National Institute Of Clinical Excellence) and local guidelines were treated. Gabapentin was given prior to general anaesthesia. Intravenous Bleomycin 15,000IU/m2 was given as a bolus. Treatment was commenced 8 minutes later with Cliniporator. Electrical pulses were delivered via an electrode inserted through the skin surface. Treatment response, disease progression free duration, post-operative pain and length of in-patient stay (LOS) were recorded. Patients recorded a symptom diary post treatment. Results: 20 treatments were performed in 16 patients from 2011-2015 with 53 separate areas treated. 8 patients had diffuse lesions, 5 had discrete lesions and 3 had both diffuse and discrete areas. 16 patients were being treated with ECT for the first time and 4 patients required 2 treatments. Median LOS was 3 days. Median follow up was 6 months (range 3-12).12 patients had complete response (75%) and 4 patients partial response. There was no disease progression for 6 months or more in 9 patients (56%) and 2 further patients had disease stabilised for 3 months with systemic or cutaneous progression in the remaining patients in 3 months or less. There were no deaths or immediate adverse events from ECT. 5 Patients (31%) with extensive diffuse chest wall disease reported persistent discomfort post treatment requiring extended period of post treatment analgesia. Conclusions: Electrochemotherapy is safe and effective treatment for cutaneous metastases. Appropriate patient selection for treatment, pre-emptive analgesia, post treatment support and follow up is essential in order to maximise the benefits and minimise potential side-effects particularly in extensive chest wall disease.

Sign in / Sign up

Export Citation Format

Share Document